摘要:
The invention provides novel macromolecules, methods for their preparation, pharmaceutical formulations thereof and their use as anti-influenza agents. The invention also provides a novel diagnostic method which can be used for detection of all types of influenza A and B virus. The macromolecular compound of the invention has attached to it one or more molecules (neuraminidase binders) which bind to the active site of influenza virus neuraminidase but which are not cleaved by the neuraminidase.
摘要:
The invention provides a method of detection of influenza virus which utilizes compounds able to bind specifically to the active site of influenza virus neuraminidase, and novel compounds for use in the method.
摘要:
Disclosed herein are compounds of formula II: wherein Alk, Z, X1, X2, R1, —R10 and R11 are defined herein, and their salts and pharmaceutically acceptable derivatives thereof, as well as other compounds of the general formula Het-A-Alk-W-Ar-C(X2)═NO-X2 where Het, A, W and Ar are also defined herein. These compounds are useful in treating picornavirus infections in mammals. Novel intermediates of these compounds, as well as pharmaceutical compositions and methods of use, are also disclosed herein.
摘要:
The invention relates to compounds of general formula (I); in which R is an amino or guanidino group; R2 is acetyl or trifluoroacetyl; X is CONH, SO2NH, NHCO or NHCONH; m is either 0 or 1; n is an integer from 2 to 6; q is an integer from 0 to 3; and Y is hydrogen or an aromatic substituent, or a pharmaceutically acceptable derivative thereof; methods for their preparation, pharmaceutical formulations containing them or their use in the prevention or treatment of a viral infection
摘要:
The invention relates to compounds of general formula (I); in which R is an amino or guanidino group; R2 is acetyl or trifluoroacetyl; X is CONH, SO2NH, NHCO or NHCONH; m is either 0 or 1; n is an integer from 2 to 6; q is an integer from 0 to 3; and Y is hydrogen or an aromatic substituent, or a pharmaceutically acceptable derivative thereof; methods for their preparation, pharmaceutical formulations containing them or their use in the prevention or treatment of a viral infection.
摘要翻译:本发明涉及通式(I)的化合物; 其中R是氨基或胍基; R 2是乙酰基或三氟乙酰基; X是CONH,SO2NH,NHCO或NHCONH; m为0或1; n为2-6的整数; q是0至3的整数; Y为氢或芳香族取代基,或其药学上可接受的衍生物; 其制备方法,含有它们的药物制剂或其在预防或治疗病毒感染中的用途。
摘要:
The invention relates to compounds of general formula (I); in which R is an amino or guanidino group; R2 is acetyl or trifluoroacetyl; X is CONH, NHCO or O; n is an integer from 2 to 6; and Y is C2–C8 alkyl C3-8 cycloalkyl, C1–C4 alkoxyalkyl, an amino acid or dipeptide, or a pharmaceutically acceptable derivative thereof, methods for their preparation, pharmaceutical formulations containing them or their use in the prevention or treatment of a viral infection
摘要:
Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid, pharmaceutical formulations thereof, methods for their preparation and their use in the treatment of viral infections, in particular influenza, are described.
摘要:
A method of promoting recovery of cell viability of a damaged respiratory cell. The method includes a step of administering to the cell at least one pharmaceutically acceptable compound, which accelerates sialyglycoconjugate biosynthesis to restore sialylglycoconjugates on the surface of the respiratory cell. Also disclosed are a method and a pharmaceutical composition, both for treating a respiratory condition.
摘要:
Compositions including polymeric dialdehydes and compounds of where R1, R2, R7, R8, R9, and R10 may be the same or different and are selected from H, CH3, OH, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl; R3, R4, R5, R6 may be the same or different and are selected from H, CH3, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl, or R5 and R6 are the same or different and are selected from H, CH3, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl and R3 and R4 together are ═O, or R4 and R6 are the same or different and are selected from H, CH3, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl and R3 and R5 together form a double bond or are ═O, or R3 and R4, are the same or different and are selected from H, CH3, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl and R5 and R6 together are ═O; R11 and R12 together form ═CH2, or R11 and R12 may be the same or different and are independently selected from the group consisting of H, CH3, CH2CH3 and CH2CH2CH3; and X is selected from the group consisting of Cl, Br, SO4, I and R13COO, where R13 is CH3 or poly acids, for the treatment of gastrointestinal functional disorders or related conditions as well as for the promotion of general health and weight gain in animals including humans.
摘要翻译:包括聚合二醛和其中R 1,R 2,R 7,R 8,R 9和R 10可以相同或不同并且选自H,CH 3,OH,OCH 3,C 2 H 5,OC 2 H 5 OCH 2 Ph,OCH 2 PhNO 2,F或Cl的化合物的组合物; R 3,R 4,R 5,R 6可以相同或不同,选自H,CH 3,OCH 3,C 2 H 5,OC 2 H 5 OCH 2 Ph,OCH 2 PhNO 2,F或Cl,或R 5和R 6相同或不同,选自H, OCH 3,C 2 H 5,OC 2 H 5 OCH 2 Ph,OCH 2 PhNO 2,F或Cl和R 3和R 4一起为=或者R 4和R 6相同或不同,并且选自H,CH 3,OCH 3,C 2 H 5,OC 2 H 5 OCH 2 Ph,OCH 2 PhNO 2,F或Cl和R 3 并且R 5和R 5一起形成双键,或者是=或者R 3和R 4相同或不同,并且选自H,CH 3,OCH 3,C 2 H 5,OC 2 H 5 OCH 2 Ph,OCH 2 PhNO 2,F或Cl和R 5和R 6一起是= R 11和R 12一起形成= CH 2,或者R 11和R 12可以相同或不同,并且独立地选自H,CH 3,CH 2 CH 3和CH 2 CH 2 CH 3; X选自Cl,Br,SO 4,I和R 13 COO,其中R 13为CH 3或多酸,用于治疗胃肠功能障碍或相关病症,以及促进一般健康和体重增加 动物包括人类。